Meet Phathom

We believe we can change the status quo of treatment for acid-related disorders.
Phathom Pharmaceuticals is a biopharmaceutical company committed to transforming the treatment landscape and improving the lives of patients suffering from acid-related gastrointestinal (GI) disorders.


Discover our in-depth experience in developing and commercializing innovative therapeutics

Our Science

View late clinical-stage programs for patients with erosive and non-erosive GERD

Investor Resources

Access our latest corporate information, upcoming events, press releases, and more